norgestrel 0.15 MG Oral Tablet
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
norgestrel 0.15 MG Oral Tablet
0.15 MG · Oral Tablet · oral
A form of norgestrel →
norgestrel 0.15 MG Oral Tablet. Strength, form, class, interactions & more.
Active ingredient
Drug interactions
The label outlines various drug interactions with norgestrel, particularly concerning hormonal contraceptives.
- majorombitasvir/paritaprevir/ritonavir — potential for ALT elevations
- moderatephenytoin — may decrease the effectiveness of COCs
- moderatebarbiturates — may decrease the effectiveness of COCs
- moderatecarbamazepine — may decrease the effectiveness of COCs
- moderatebosentan — may decrease the effectiveness of COCs
- moderatefelbamate — may decrease the effectiveness of COCs
- moderategriseofulvin — may decrease the effectiveness of COCs
- moderateoxcarbazepine — may decrease the effectiveness of COCs
- moderaterifampicin — may decrease the effectiveness of COCs
- moderatetopiramate — may decrease the effectiveness of COCs
- moderaterifabutin — may decrease the effectiveness of COCs
- moderaterufinamide — may decrease the effectiveness of COCs
- moderateaprepitant — may decrease the effectiveness of COCs
- moderateSt. John's wort — may decrease the effectiveness of COCs
- moderatecolesevelam — significantly decrease the AUC of EE
- moderateatorvastatin — increase AUC values for EE
- moderaterosuvastatin — increase AUC values for EE
- moderateascorbic acid — may increase plasma EE concentrations
- moderateacetaminophen — may increase plasma EE concentrations
- moderateitraconazole — may increase plasma hormone concentrations
- moderatefluconazole — may increase plasma hormone concentrations
- moderategrapefruit juice — may increase plasma hormone concentrations
- moderateketoconazole — may increase plasma hormone concentrations
- moderatenelfinavir — decrease plasma concentrations of estrogen and/or progestin
- moderateritonavir — decrease plasma concentrations of estrogen and/or progestin
- moderatedarunavir/ritonavir — decrease plasma concentrations of estrogen and/or progestin
- moderate(fos) amprenavir/ritonavir — decrease plasma concentrations of estrogen and/or progestin
- moderatelopinavir/ritonavir — decrease plasma concentrations of estrogen and/or progestin
- moderatetipranavir/ritonavir — decrease plasma concentrations of estrogen and/or progestin
- moderateindinavir — increase plasma concentrations of estrogen and/or progestin
- moderateatazanavir/ritonavir — increase plasma concentrations of estrogen and/or progestin
- moderatenevirapine — decrease plasma concentrations of estrogen and/or progestin
- moderateetravirine — increase plasma concentrations of estrogen and/or progestin
- moderatecyclosporine — increase plasma concentrations
- moderateprednisolone — increase plasma concentrations
- moderatetheophylline — increase plasma concentrations
- moderatetizanidine — increase plasma concentrations
- moderatevoriconazole — increase plasma concentrations
- moderateacetaminophen — decrease plasma concentrations
- moderateclofibric acid — decrease plasma concentrations
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication